131 related articles for article (PubMed ID: 8649940)
21. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
22. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure.
Lu KC; Shieh SD; Lin SH; Chyr SH; Lin YF; Diang LK; Li BL; Sheu WH; Ding YA
Q J Med; 1994 Jun; 87(6):359-65. PubMed ID: 8041868
[TBL] [Abstract][Full Text] [Related]
23. Calcium-free hemodialysis is useful for evaluating parathyroid function and bone disease in chronic hemodialysis patients.
Ohira S; Abe K; Nakamura K; Nagayama K
Clin Nephrol; 1995 Nov; 44 Suppl 1():S48-50. PubMed ID: 8608663
[TBL] [Abstract][Full Text] [Related]
24. [Phosphorus and calcium metabolism and its hormonal regulation in chronic kidney failure].
Nikiforova NV; Strunin SE; Ermolenko VM; Mozzhechkov VT; Khomiakova VN
Ter Arkh; 1985; 57(1):103-7. PubMed ID: 3983831
[TBL] [Abstract][Full Text] [Related]
25. Level-dependent inhibitory effect of hyperaluminaemia on parathyroid hormone secretion in patients with end-stage renal failure.
Fernández E; Amoedo ML; Montoliu J
Eur J Med; 1992 Dec; 1(8):482-4. PubMed ID: 1341207
[TBL] [Abstract][Full Text] [Related]
26. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
[TBL] [Abstract][Full Text] [Related]
27. Relationship between serum intact parathyroid hormone and pruritus in hemodialysis patients.
Makhlough A; Emadi N; Sedighi O; Khademloo M; Bicmohamadi AR
Iran J Kidney Dis; 2013 Jan; 7(1):42-6. PubMed ID: 23314141
[TBL] [Abstract][Full Text] [Related]
28. [Use of the equipment for hemodialysis in the diagnosis of calcium metabolism disorders in terminal chronic renal failure].
Ermakova IP; Novikov AI; Pronchenko IA; Sokolova TIu; Baeva LB; Ermolenko AE; Levitskiĭ ER
Med Tekh; 1991; (1):27-9. PubMed ID: 2038254
[TBL] [Abstract][Full Text] [Related]
29. Low Ca2+ dialysate. Effects on bone metabolism in the course of paired filtration dialysis.
Carozzi S; Nasini MG; Pietrucci A; Costa M; Mantero R
ASAIO J; 1994; 40(3):M683-5. PubMed ID: 8555601
[TBL] [Abstract][Full Text] [Related]
30. Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism.
Goodman WG; Belin T; Gales B; Juppner H; Segre GV; Salusky IB
Kidney Int; 1995 Nov; 48(5):1553-8. PubMed ID: 8544413
[TBL] [Abstract][Full Text] [Related]
31. Variability in calcium, phosphorus, and parathyroid hormone in patients on hemodialysis.
Levitt H; Smith KG; Rosner MH
Hemodial Int; 2009 Oct; 13(4):518-25. PubMed ID: 19758299
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D receptor gene polymorphism detected by digestion with Apa I influences the parathyroid response to extracellular calcium in Japanese chronic dialysis patients.
Yokoyama K; Shigematsu T; Kagami S; Tsukada T; Arai T; Hara S; Yamada A; Kawaguchi Y; Hosoya T
Nephron; 2001 Nov; 89(3):315-20. PubMed ID: 11598396
[TBL] [Abstract][Full Text] [Related]
33. The negative Ca(2+) balance is involved in the stimulation of PTH secretion.
Yokoyama K; Kagami S; Ohkido I; Kato N; Yamamoto H; Shigematsu T; Nakayama M; Fukagawa M; Kawaguchi Y; Hosoya T
Nephron; 2002 Sep; 92(1):86-90. PubMed ID: 12187089
[TBL] [Abstract][Full Text] [Related]
34. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease.
Felsenfeld AJ; Ross D; Rodriguez M
J Am Soc Nephrol; 1991 Dec; 2(6):1136-43. PubMed ID: 1777594
[TBL] [Abstract][Full Text] [Related]
35. Hyperparathyroidism in the hemodialysis population: a survey of 612 patients.
Salem MM
Am J Kidney Dis; 1997 Jun; 29(6):862-5. PubMed ID: 9186071
[TBL] [Abstract][Full Text] [Related]
36. Clinical benefit of the change of dialysate calcium concentration from 3.0 to 2.75 mEq/L.
Sakai Y; Otsuka T; Ohno D; Murasawa T; Sakai S; Tsuruoka S
Ther Apher Dial; 2014 Apr; 18(2):181-4. PubMed ID: 24720409
[TBL] [Abstract][Full Text] [Related]
37. Effect of lower calcium dialysate on laboratory abnormalities in chronic kidney disease-associated mineral and bone disorder.
Bansal A; Sandhu G; Chitale RA; Jones J; Meisels IS
Am J Ther; 2012 Nov; 19(6):429-31. PubMed ID: 22020086
[TBL] [Abstract][Full Text] [Related]
38. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].
Starzyk J; Kowalski D
Wiad Lek; 1993 Apr; 46(7-8):283-5. PubMed ID: 8249416
[TBL] [Abstract][Full Text] [Related]
39. Low-calcium peritoneal dialysis solution is effective in bringing PTH levels to the range recommended by current guidelines in patients with PTH levels < 150 pg/dL.
Moraes TP; Bucharles SG; Ribeiro SC; Frumento R; Riella MC; Pecoits-Filho R
J Bras Nefrol; 2010; 32(3):275-80. PubMed ID: 21103691
[TBL] [Abstract][Full Text] [Related]
40. Calcium and phosphorus metabolism in maintenance hemodialysis.
Ritz E; Mehls O; Krempien B
Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
